According to the National Institutes of Health, one in three women in the U.S. will undergo a hysterectomy by the age of 60.
Author: Global Cancer Consortium
MannKind is a biopharmaceutical company that actualizes therapeutics for the treatment of diabetes and cancer, and has also developed a novel inhalation-based drug delivery system that enables enhanced…
Infinity Pharmaceuticals is a biopharmaceutical company that has developed a targeted drug development platform to actualize small molecule inhibitors against specific bioactive proteins that play critical roles in biological…
Cancer drug sales are slowing down in the U.S., Reuters reported Monday.
Advanced Life Sciences (OTC BB: ADLS) took two steps this week toward advancing its lead drug candidate, Restanza.
Wired magazine recently published a feature on Cytori Therapeutics, a regenerative medicine company based in San Diego that is using stem and regenerative stem cells derived from fat (adipose) tissue to repair breasts disfigured by mastectomies and lumpectomies.
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
This company is a specialty biopharmaceutical company that has established a drug development platform to actualize an orally administered, low-dose version of the drug interferon, which is a well characterized immune system modulator. Interferon serves as one of the most…